Original from: genomeweb

Helio Genomics said Monday that it has partnered to offer its LiverTrace at-home blood test for liver cancer in partnership with liver health telemedicine firm LiverRight.

LiverTrace is designed to analyze cell-free DNA methylation patterns and serum protein biomarkers in blood samples to detect liver cancer. It is available to consumers directly from Irvine, California-based Helio.

Under the terms of the deal, individuals who order the test will have the option to contact LiverRight hepatologists and hepatology care providers to help interpret the results and proceed toward formal diagnosis if appropriate.

Financial and other terms were not disclosed.

Source: Helio Genomics, Telemedicine Firm LiverRight Partner on Liver Cancer Dx